Update of the tolerable upper intake level for vitamin D for infants

K. Pentieva, Dominique Turck, Jean‐Louis Bresson, Barbara Burlingame, Tara Dean, Susan Fairweather‐Tait, Marina Heinonen, Karen Ildico Hirsch‐Ernst, Inge Mangelsdorf, Harry J McArdle, Androniki Naska, Grazyna Nowicka, Yolanda Sanz, Alfonso Siani, Anders Sjodin, Martin Stern, Daniel Tome, Henk Van Loveren, Marco Vinceti, Peter WillattsMary Fewtrell, Christel Lamberg-Allardt, Hildegard Przyrembel, Davide Arcella, Celine Dumas, Lucia Fabiani, Laura Martino, Daniela Tomcikova, Monika Neuhauser-Berthold

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to revise the tolerable upper intake level (UL) for vitamin D for infants (≤ 1 year) set in 2012. From its literature review, the Panel concluded that the available evidence on daily vitamin D intake and the risk of adverse health outcomes (hypercalciuria, hypercalcaemia, nephrocalcinosis and abnormal growth patterns) cannot be used alone for deriving the UL for infants. The Panel conducted a meta‐regression analysis of collected data, to derive a dose–response relationship between daily supplemental intake of vitamin D and mean achieved serum 25(OH)D concentrations. Considering that a serum 25(OH)D concentration of 200 nmol/L or below is unlikely to pose a risk of adverse health outcomes in infants, the Panel estimated the percentage of infants reaching a concentration above this value at different intakes of vitamin D. Based on the overall evidence, the Panel kept the UL of 25 μg/day for infants aged up to 6 months and set a UL of 35 μg/day for infants 6–12 months. The Panel was also asked to advise on the safety of the consumption of infant formulae with an increased maximum vitamin D content of 3 μg/100 kcal (Commission Delegated Regulation (EU) 2016/127 repealing Directive 2006/141/EC in 2020). For infants aged up to 4 months, the intake assessment showed that the use of infant formulae containing vitamin D at 3 μg/100 kcal may lead some infants to receive an intake above the UL of 25 μg/day from formulae alone without considering vitamin D supplemental intake. For infants aged 4–12 months, the 95th percentile of vitamin D intake (high consumers) estimated from formulae and foods fortified or not with vitamin D does not exceed the ULs, without considering vitamin D supplemental intake.
Original languageEnglish
Number of pages118
JournalEFSA Journal
Volume16
Issue number8
DOIs
Publication statusPublished - 7 Aug 2018

Keywords

  • vitamin D
  • infants
  • adverse health outcome
  • 25(OH)D
  • UL
  • Intake

Fingerprint Dive into the research topics of 'Update of the tolerable upper intake level for vitamin D for infants'. Together they form a unique fingerprint.

  • Cite this

    Pentieva, K., Turck, D., Bresson, JL., Burlingame, B., Dean, T., Fairweather‐Tait, S., Heinonen, M., Ildico Hirsch‐Ernst, K., Mangelsdorf, I., McArdle, H. J., Naska, A., Nowicka, G., Sanz, Y., Siani, A., Sjodin, A., Stern, M., Tome, D., Van Loveren, H., Vinceti, M., ... Neuhauser-Berthold, M. (2018). Update of the tolerable upper intake level for vitamin D for infants. EFSA Journal, 16(8). https://doi.org/10.2903/j.efsa.2018.5365